Copyright Reports & Markets. All rights reserved.

Global Rivaroxaban Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Rivaroxaban Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 2.5mg/Tablet
    • 1.3.3 10mg/Tablet
    • 1.3.4 15mg/Tablet
    • 1.3.5 20mg/Tablet
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Rivaroxaban Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Drugstore
  • 1.5 Global Rivaroxaban Tablets Market Size & Forecast
    • 1.5.1 Global Rivaroxaban Tablets Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Rivaroxaban Tablets Sales Quantity (2021-2032)
    • 1.5.3 Global Rivaroxaban Tablets Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Bayer
    • 2.1.1 Bayer Details
    • 2.1.2 Bayer Major Business
    • 2.1.3 Bayer Rivaroxaban Tablets Product and Services
    • 2.1.4 Bayer Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Bayer Recent Developments/Updates
  • 2.2 Janssen Pharmaceuticals
    • 2.2.1 Janssen Pharmaceuticals Details
    • 2.2.2 Janssen Pharmaceuticals Major Business
    • 2.2.3 Janssen Pharmaceuticals Rivaroxaban Tablets Product and Services
    • 2.2.4 Janssen Pharmaceuticals Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Janssen Pharmaceuticals Recent Developments/Updates
  • 2.3 Beijing SL Pharmaceutical
    • 2.3.1 Beijing SL Pharmaceutical Details
    • 2.3.2 Beijing SL Pharmaceutical Major Business
    • 2.3.3 Beijing SL Pharmaceutical Rivaroxaban Tablets Product and Services
    • 2.3.4 Beijing SL Pharmaceutical Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Beijing SL Pharmaceutical Recent Developments/Updates
  • 2.4 Nanjing Zhengda Tianqing Pharmaceutical
    • 2.4.1 Nanjing Zhengda Tianqing Pharmaceutical Details
    • 2.4.2 Nanjing Zhengda Tianqing Pharmaceutical Major Business
    • 2.4.3 Nanjing Zhengda Tianqing Pharmaceutical Rivaroxaban Tablets Product and Services
    • 2.4.4 Nanjing Zhengda Tianqing Pharmaceutical Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Nanjing Zhengda Tianqing Pharmaceutical Recent Developments/Updates
  • 2.5 Fujian Cosunter Pharmaceutical
    • 2.5.1 Fujian Cosunter Pharmaceutical Details
    • 2.5.2 Fujian Cosunter Pharmaceutical Major Business
    • 2.5.3 Fujian Cosunter Pharmaceutical Rivaroxaban Tablets Product and Services
    • 2.5.4 Fujian Cosunter Pharmaceutical Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Fujian Cosunter Pharmaceutical Recent Developments/Updates
  • 2.6 Lunan Pharmaceutical
    • 2.6.1 Lunan Pharmaceutical Details
    • 2.6.2 Lunan Pharmaceutical Major Business
    • 2.6.3 Lunan Pharmaceutical Rivaroxaban Tablets Product and Services
    • 2.6.4 Lunan Pharmaceutical Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Lunan Pharmaceutical Recent Developments/Updates
  • 2.7 Shanghai Huilun Pharmaceutical
    • 2.7.1 Shanghai Huilun Pharmaceutical Details
    • 2.7.2 Shanghai Huilun Pharmaceutical Major Business
    • 2.7.3 Shanghai Huilun Pharmaceutical Rivaroxaban Tablets Product and Services
    • 2.7.4 Shanghai Huilun Pharmaceutical Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Shanghai Huilun Pharmaceutical Recent Developments/Updates
  • 2.8 Jilin Boda Pharmaceutical
    • 2.8.1 Jilin Boda Pharmaceutical Details
    • 2.8.2 Jilin Boda Pharmaceutical Major Business
    • 2.8.3 Jilin Boda Pharmaceutical Rivaroxaban Tablets Product and Services
    • 2.8.4 Jilin Boda Pharmaceutical Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Jilin Boda Pharmaceutical Recent Developments/Updates
  • 2.9 Cspc Holdings Company
    • 2.9.1 Cspc Holdings Company Details
    • 2.9.2 Cspc Holdings Company Major Business
    • 2.9.3 Cspc Holdings Company Rivaroxaban Tablets Product and Services
    • 2.9.4 Cspc Holdings Company Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Cspc Holdings Company Recent Developments/Updates
  • 2.10 Zhejiang Conba Pharmaceutical
    • 2.10.1 Zhejiang Conba Pharmaceutical Details
    • 2.10.2 Zhejiang Conba Pharmaceutical Major Business
    • 2.10.3 Zhejiang Conba Pharmaceutical Rivaroxaban Tablets Product and Services
    • 2.10.4 Zhejiang Conba Pharmaceutical Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Zhejiang Conba Pharmaceutical Recent Developments/Updates
  • 2.11 Suzhou No.3 Pharmaceutical
    • 2.11.1 Suzhou No.3 Pharmaceutical Details
    • 2.11.2 Suzhou No.3 Pharmaceutical Major Business
    • 2.11.3 Suzhou No.3 Pharmaceutical Rivaroxaban Tablets Product and Services
    • 2.11.4 Suzhou No.3 Pharmaceutical Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Suzhou No.3 Pharmaceutical Recent Developments/Updates
  • 2.12 Chengdu Baiyu Pharmaceuticals
    • 2.12.1 Chengdu Baiyu Pharmaceuticals Details
    • 2.12.2 Chengdu Baiyu Pharmaceuticals Major Business
    • 2.12.3 Chengdu Baiyu Pharmaceuticals Rivaroxaban Tablets Product and Services
    • 2.12.4 Chengdu Baiyu Pharmaceuticals Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Chengdu Baiyu Pharmaceuticals Recent Developments/Updates
  • 2.13 Jiangsu Zhongbang Pharmaceutical
    • 2.13.1 Jiangsu Zhongbang Pharmaceutical Details
    • 2.13.2 Jiangsu Zhongbang Pharmaceutical Major Business
    • 2.13.3 Jiangsu Zhongbang Pharmaceutical Rivaroxaban Tablets Product and Services
    • 2.13.4 Jiangsu Zhongbang Pharmaceutical Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Jiangsu Zhongbang Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Rivaroxaban Tablets by Manufacturer

  • 3.1 Global Rivaroxaban Tablets Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Rivaroxaban Tablets Revenue by Manufacturer (2021-2026)
  • 3.3 Global Rivaroxaban Tablets Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Rivaroxaban Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Rivaroxaban Tablets Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Rivaroxaban Tablets Manufacturer Market Share in 2025
  • 3.5 Rivaroxaban Tablets Market: Overall Company Footprint Analysis
    • 3.5.1 Rivaroxaban Tablets Market: Region Footprint
    • 3.5.2 Rivaroxaban Tablets Market: Company Product Type Footprint
    • 3.5.3 Rivaroxaban Tablets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Rivaroxaban Tablets Market Size by Region
    • 4.1.1 Global Rivaroxaban Tablets Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Rivaroxaban Tablets Consumption Value by Region (2021-2032)
    • 4.1.3 Global Rivaroxaban Tablets Average Price by Region (2021-2032)
  • 4.2 North America Rivaroxaban Tablets Consumption Value (2021-2032)
  • 4.3 Europe Rivaroxaban Tablets Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Rivaroxaban Tablets Consumption Value (2021-2032)
  • 4.5 South America Rivaroxaban Tablets Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Rivaroxaban Tablets Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Rivaroxaban Tablets Sales Quantity by Type (2021-2032)
  • 5.2 Global Rivaroxaban Tablets Consumption Value by Type (2021-2032)
  • 5.3 Global Rivaroxaban Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Rivaroxaban Tablets Sales Quantity by Application (2021-2032)
  • 6.2 Global Rivaroxaban Tablets Consumption Value by Application (2021-2032)
  • 6.3 Global Rivaroxaban Tablets Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Rivaroxaban Tablets Sales Quantity by Type (2021-2032)
  • 7.2 North America Rivaroxaban Tablets Sales Quantity by Application (2021-2032)
  • 7.3 North America Rivaroxaban Tablets Market Size by Country
    • 7.3.1 North America Rivaroxaban Tablets Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Rivaroxaban Tablets Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Rivaroxaban Tablets Sales Quantity by Type (2021-2032)
  • 8.2 Europe Rivaroxaban Tablets Sales Quantity by Application (2021-2032)
  • 8.3 Europe Rivaroxaban Tablets Market Size by Country
    • 8.3.1 Europe Rivaroxaban Tablets Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Rivaroxaban Tablets Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Rivaroxaban Tablets Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Rivaroxaban Tablets Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Rivaroxaban Tablets Market Size by Region
    • 9.3.1 Asia-Pacific Rivaroxaban Tablets Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Rivaroxaban Tablets Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Rivaroxaban Tablets Sales Quantity by Type (2021-2032)
  • 10.2 South America Rivaroxaban Tablets Sales Quantity by Application (2021-2032)
  • 10.3 South America Rivaroxaban Tablets Market Size by Country
    • 10.3.1 South America Rivaroxaban Tablets Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Rivaroxaban Tablets Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Rivaroxaban Tablets Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Rivaroxaban Tablets Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Rivaroxaban Tablets Market Size by Country
    • 11.3.1 Middle East & Africa Rivaroxaban Tablets Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Rivaroxaban Tablets Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Rivaroxaban Tablets Market Drivers
  • 12.2 Rivaroxaban Tablets Market Restraints
  • 12.3 Rivaroxaban Tablets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Rivaroxaban Tablets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Rivaroxaban Tablets
  • 13.3 Rivaroxaban Tablets Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Rivaroxaban Tablets Typical Distributors
  • 14.3 Rivaroxaban Tablets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Rivaroxaban Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Rivaroxaban tablets are anticoagulants (blood thinners) used to treat and prevent blood clots. Specifically, it is used to treat deep vein thrombosis and pulmonary embolism, and to prevent atrial fibrillation and blood clots after hip or knee surgery. It is taken orally. Common side effects include bleeding. Other serious side effects may include spinal epidural hematoma and anaphylactic shock. It is not known if it is safe to use during pregnancy and breastfeeding. It has fewer interactions with other drugs than warfarin. It works by blocking the activity of the clotting protein coagulation factor Xa.
    This report is a detailed and comprehensive analysis for global Rivaroxaban Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Rivaroxaban Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Boxes), and average selling prices (US$/Box), 2021-2032
    Global Rivaroxaban Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Boxes), and average selling prices (US$/Box), 2021-2032
    Global Rivaroxaban Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Boxes), and average selling prices (US$/Box), 2021-2032
    Global Rivaroxaban Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Boxes), and ASP (US$/Box), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Rivaroxaban Tablets
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Rivaroxaban Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Janssen Pharmaceuticals, Beijing SL Pharmaceutical, Nanjing Zhengda Tianqing Pharmaceutical, Fujian Cosunter Pharmaceutical, Lunan Pharmaceutical, Shanghai Huilun Pharmaceutical, Jilin Boda Pharmaceutical, Cspc Holdings Company, Zhejiang Conba Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Rivaroxaban Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    2.5mg/Tablet
    10mg/Tablet
    15mg/Tablet
    20mg/Tablet
    Market segment by Application
    Hospital
    Clinic
    Drugstore
    Major players covered
    Bayer
    Janssen Pharmaceuticals
    Beijing SL Pharmaceutical
    Nanjing Zhengda Tianqing Pharmaceutical
    Fujian Cosunter Pharmaceutical
    Lunan Pharmaceutical
    Shanghai Huilun Pharmaceutical
    Jilin Boda Pharmaceutical
    Cspc Holdings Company
    Zhejiang Conba Pharmaceutical
    Suzhou No.3 Pharmaceutical
    Chengdu Baiyu Pharmaceuticals
    Jiangsu Zhongbang Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Rivaroxaban Tablets product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Rivaroxaban Tablets, with price, sales quantity, revenue, and global market share of Rivaroxaban Tablets from 2021 to 2026.
    Chapter 3, the Rivaroxaban Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Rivaroxaban Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Rivaroxaban Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Rivaroxaban Tablets.
    Chapter 14 and 15, to describe Rivaroxaban Tablets sales channel, distributors, customers, research findings and conclusion.

    Buy now